Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK

Integrated genomic analyses of ovarian carcinoma

Debra Bell, Andrew Berchuck, Narciso Olvera et al. · Nature · 2011 · 8.2K citations · Full text

Medicine, Genetics, Oncology +14

Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

Deborah Ford, Douglas F. Easton, Michael R. Stratton et al. · The American Journal of Human Genetics · 1998 · 3K citations · Full text

Life Sciences, Genetics, Oncology +17

Breast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Mary‐Claire King, Joan H. Marks, Jessica B. Mandell · Science · 2003 · 2.2K citations

Medicine, Genetics, Oncology +17

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Douglas F. Easton, Deborah Ford, D. Timothy Bishop · PubMed · 1995 · 1.6K citations

Medicine, Genetics, Oncology +16

Association of Risk-Reducing Surgery in &lt;emph type="ital"&gt;BRCA1&lt;/emph&gt; or &lt;emph type="ital"&gt;BRCA2&lt;/emph&gt; Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek · JAMA · 2010 · 1.5K citations · Full text

Medicine, Gynecology, Oncology +17